Controlled drug release from pharmaceutical nanocarriers

被引:328
|
作者
Lee, Jinhyun Hannah [1 ,2 ]
Yeo, Yoon [1 ,2 ,3 ]
机构
[1] Purdue Univ, Coll Pharm, W Lafayette, IN 47907 USA
[2] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA
[3] Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea
基金
美国国家科学基金会;
关键词
Nanocarriers; Controlled release; Drug delivery; Drug release kinetics; Drug release mechanisms; MESOPOROUS SILICA NANOPARTICLES; RESPONSIVE CONTROLLED-RELEASE; LOADED PLGA NANOPARTICLES; HOLLOW GOLD NANOSPHERES; POLYMERIC MICELLES; IN-VITRO; MACROMOLECULAR THERAPEUTICS; SUSTAINED-RELEASE; DELIVERY-SYSTEM; ANTICANCER DRUG;
D O I
10.1016/j.ces.2014.08.046
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Nanocarriers providing spatiotemporal control of drug release contribute to reducing toxicity and improving therapeutic efficacy of a drug. On the other hand, nanocarriers face unique challenges in controlling drug release kinetics, due to the large surface area per volume ratio and the short diffusion distance. To develop nanocarriers with desirable release kinetics for target applications, it is important to understand the mechanisms by which a carrier retains and releases a drug, the effects of composition and morphology of he carrier on the drug release kinetics, and current techniques for preparation and modification of nanocarriers. This review provides an overview of drug release mechanisms and various nanocarriers with a specific emphasis on approaches to control the drug release kinetics. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 50 条